RNL Bio, a South Korean biotech company, is venturing into the world of treating human diseases through stem cell therapies, raising the prospects of a new, highly profitable export industry.
The company, famous for the commercial cloning of dogs, is developing therapies using adult stem cells to treat degenerative diseases
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/stem-cell-research-opens-prospect-profitable-exports
[2] http://admin.indiaenvironmentportal.org.in/category/newspaper/financial-times-london
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/medical-research
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/genetic-cloning
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/south-korea
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/biotechnology-industry
